Change Initiative https://validator.w3.org/feed/docs/rss2.html Home US Policy Horizon Series: From Washington to the World Financing Prevention: Unlocking Investment in a Healthier Future Cookies Privacy and terms Contact Us Partner With Us From Washington to the World: News Feed Three Models of MFN Announced Supreme Court rejects Trump’s tariffs: What does this mean for pharma? Is the revised Congressional Budget Office model of new drug development fit for purpose? Most Favored Nation pricing: what it means for policy, patients and pharma How US drug pricing reforms are reshaping biopharma investment and innovation Europe’s pharmaceutical policy choices – And what the United States stands to learn Trump Administration announces 100% tariffs on pharmaceuticals Our Research Areas